🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to determine the effect of two dose strength...
Status
Completed
Location
Acorda Site #117
Start Date
2014-12
Trial ID
NCT02271217
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of a lo...
Status
Completed
Location
North Central Neurology Associates, PC
Start Date
2011-03
Trial ID
NCT01328379
Treatments Being Tested
This study evaluates the effects of sustained-release oral dalfampridine in...
Status
Unknown
Location
Multiple Sclerosis Center
Start Date
2014-11
Trial ID
NCT02259361
Treatments Being Tested
The purpose of this study is to see if the study drug 4-aminopyridine (4-AP...
Status
Withdrawn
Location
University of Rochester Medical Center
Start Date
2018-10-03
Trial ID
NCT03658408
Treatments Being Tested
Cognitive impairment is common in multiple sclerosis (MS) and has devastati...
Status
Completed
Location
Buffalo General Hospital
Start Date
2011-12
Trial ID
NCT02006160
Treatments Being Tested
Fampyra, a voltage-dependent potassium channel blocker, is indicated for th...
Status
Completed
Location
Αiginitio hospital
Start Date
2017-03-07
Trial ID
NCT03164018
Treatments Being Tested
The goal of this interventional double blind, randomized placebo controlled...
Status
Completed
Location
Multiple Locations
Start Date
2011-07-13
Trial ID
NCT05859802
Treatments Being Tested
The study objectives are to descript clinical, biological and echocardiogra...
Status
Completed
Location
Hôpital Bicêtre
Start Date
2020-06-10
Trial ID
NCT04420468
Mobility problems in multiple sclerosis (MS) is a frequent symptom. It migh...
Status
Unknown
Location
Hospital General Universitario Gregorio Marañón
Start Date
2016-12
Trial ID
NCT02966808
Treatments Being Tested
Hypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myast...
Status
Completed
Location
University of California at Davis
Start Date
2012-01
Trial ID
NCT01511978
Treatments Being Tested